Posted by Michael Wonder on 06 Sep 2016
Hillary's new (generic) drug price proposal: better than expected
2 September 2016 - What better time for a presidential candidate to release a drug pricing plan than when the EpiPen pricing scandal in full swing?
Adding to her previous proposal focusing on patient cost-sharing for drugs, Hillary Clinton has now announced several new ideas to address drug pricing (primarily) in the generic market. All in all, there are some decent ideas, despite some glaring flaws.
